Skip to main content
. 2010 Nov;131(3):371–376. doi: 10.1111/j.1365-2567.2010.03308.x

Figure 2.

Figure 2

Soluble (s) CD25 is increased in chronic lymphocytic leukaemia (CLL) and lymphoma plasma. Plasma from CLL patients (n = 12), B-cell lymphoma patients (n = 14) and healthy controls (n = 27) was analysed for the presence of sCD25 using enzyme-linked immunosorbent assay. Patients displayed a significantly higher level of soluble CD25 than healthy individuals. Mann–Whitney U-test was used to calculate significant differences.